The XACT Robotic System is based on research originally conducted at the Technion – Israel Institute of Technology, by Moshe Shoham, founder of Mazor Robotics, which was acquired by Medtronic in 2018.Headshot courtesy of XACT Robotics; graphic by Amanda Pedersen
Competitors in the robotic-assisted surgical space would also do well to keep an eye on Caesarea, Isreal-based XACT Robotics, which just received FDA clearance to sell its first robotic system in the United States. The robot was cleared for use during CT-guided percutaneous interventional procedures.
The wow factor of the Xact robot is that it is the first hands-free robotic system combining image-based planning and navigation with the insertion and steering of various instruments across an array of clinical applications and indications.
“We are committed to redefining the way the entire medical community utilizes robotics, beginning with interventional radiologists,” said Harel Gadot, the company's founder, executive chairman, and president. “Being the first to introduce a hands-free robotic system, we have the potential to provide significant clinical, technical, and economic value while democratizing interventional procedures. Our system’s small footprint and high mobility design will enable care providers to treat a broad range of patient care needs in various clinical sites of service.”
The XACT Robotic System is based on research originally conducted at the Technion – Israel Institute of Technology, by Moshe Shoham, founder of Mazor Robotics, which was acquired by Medtronic in 2018 in a $1.6 billion deal. The company plans to launch the system to select U.S. radiology centers and will debut its technology at the 2019 Radiological Society of North America (RSNA) conference next month in Chicago, IL.